CANDRIAM S.C.A. Mirati Therapeutics, Inc. Transaction History

CANDRIAM S.C.A. portfolio value:

$46.27M
portfolio value

CANDRIAM S.C.A. quarter portfolio value change:

+4.04%
quarter

Mirati Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +11.48% 68.21K shares 6.37M $69.84 662.50K
Q2 2022 share Increase +17.27% 87.51K shares -1.77M $67.13 594.28K
Q1 2022 share Increase +2.90% 14.29K shares -30.57M $82.22 506.77K
Q4 2021 share Increase +28.51% 109.26K shares 4.44M $148.23 492.48K
Q3 2021 share Increase +10.89% 37.62K shares 11.96M $176.91 383.21K
Q2 2021 share Increase +82.76% 156.49K shares 15.92M $161.53 345.59K
Q1 2021 share Increase 0.00% 2 shares -1.64M $171.3 189.1K
Q4 2020 share Increase +42.03% 55.96K shares 19.42M $219.64 189.09K
Q3 2020 share Increase +20.97% 23.08K shares 9.54M $166.05 133.13K
Q2 2020 share Increase +10.81% 10.73K shares 55K $114.17 110.05K
Q1 2020 share 0.00% 0 shares -288K $76.87 99.32K
Q4 2019 share Decrease -18.79% -22.97K shares 3.27M $128.86 99.32K
Q3 2019 share Decrease -22.10% -34.7K shares -6.57M $77.91 122.3K
Q2 2019 share Increase +38.94% 44K shares 7.81M $103 157K
Q1 2019 share Decrease -46.45% -98K shares -667K $73.3 113K
Q4 2018 share Increase +9.90% 19K shares -93K $42.42 211K
Q3 2018 share Increase +107.12% 99.3K shares 4.47M $47.1 192K
Q2 2018 share Increase 0.00% 92.7K shares 4.57M $49.3 92.7K
Q3 2016 share Decrease -100.00% -70K shares -382K $6.61 0
Q2 2016 share Decrease -32.69% -34K shares -1.83M $5.46 70K
Q1 2016 share Decrease -9.57% -11K shares -1.42M $21.4 104K